Filing Details
- Accession Number:
- 0001144204-16-087140
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-10 14:05:26
- Reporting Period:
- 2016-03-09
- Filing Date:
- 2016-03-10
- Accepted Time:
- 2016-03-10 14:05:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488039 | Atossa Genetics Inc | ATOS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008227 | C Steven Quay | C/O Atossa Genetics, Inc. 2300 Eastlake Ave. East, Suite 200 Seattle WA 98102 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-09 | 15,000 | $0.37 | 4,826,858 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents 15,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
- Consists of: (i) 4,348,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"), and (ii) 478,543 shares of common stock owned directly by Dr. Quay. Shu-Chih Chen, Ph.D. and Dr. Quay share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Quay and Chen, and, as a result, Drs. Quay and Chen are deemed to be beneficial owners of the shares held by this entity.
Billionaire Hedge Funds
